Literature DB >> 26960716

Gene Mutation in Neonatal Jaundice - Mutations in UGT1A1 and OATP2 Genes.

Jiang Min1, Luo Jie2, Yang Caiyun2, Lin Ying2, Yang Xuefang2.   

Abstract

This study evaluated the correlation of UGT1A1, OATP2 gene mutations and hyperbilirubinemia in newborns in Northern China. Gene mutations were analyzed at the 211 locus of UGT1A1 (Gly71Arg) and 388 locus of OATP2 (Asn130Asp). The 226 enrolled infants were divided into high, moderate, and low risk subgroups according to American Academy of Pediatrics guideline. Blood samples of the enrolled infants were collected for the analysis of the PCR-restriction fragment length polymorphism. The genotypes and allele frequencies of the polymorphisms were compared in each group. Both UGT1A1 and OATP2 gene mutations occur more often in high risk group and moderate risk group than in low risk group. The results suggested that Gly71Arg and Asn130Asp mutations in UGT1A1 and OATP2 genes might be involved in the development of hyperbilirubinemia in neonates.

Entities:  

Keywords:  Genetic mutation; Hyperbilirubinemia; Newborn; OATP2; UGT1A1

Mesh:

Substances:

Year:  2016        PMID: 26960716     DOI: 10.1007/s12098-016-2064-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  Prevalence of uridine glucuronosyl transferase 1A1 (UGT1A1) mutations in Malay neonates with severe jaundice.

Authors:  I Azlin; F L Wong; M Ezham; A Hafiza; O Ainoon
Journal:  Malays J Pathol       Date:  2011-12       Impact factor: 0.656

2.  Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-κB leads to hyperbilirubinemia.

Authors:  Ryoichi Fujiwara; Shujuan Chen; Michael Karin; Robert H Tukey
Journal:  Gastroenterology       Date:  2011-10-06       Impact factor: 22.682

3.  [Role of genetic factors in occurrence of neonatal jaundice in Guangxi region].

Authors:  Wen-ping Fu; Yi Liu
Journal:  Zhonghua Er Ke Za Zhi       Date:  2005-10

4.  Screening for G71R mutation of the UDP-glucuronosyltransferase 1 (UGT1A1) gene in neonates with pathologic and prolonged hyperbilirubinemia in Turkey.

Authors:  I Kilic; A Koseler; I Cakaloz; E Atalay
Journal:  Int J Clin Pharmacol Ther       Date:  2010-08       Impact factor: 1.366

5.  Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia.

Authors:  Paula S Montenegro-Miranda; Nina Sneitz; D Rudi de Waart; Lysbeth Ten Bloemendaal; Suzanne Duijst; Robert J de Knegt; Ulrich Beuers; Moshe Finel; Piter J Bosma
Journal:  Biochim Biophys Acta       Date:  2012-04-21

6.  Risk factors for severe hyperbilirubinemia in neonates.

Authors:  May-Jen Huang; Ka-Em Kua; Hsiu-Chen Teng; Kung-Sheng Tang; Hui-Wen Weng; Ching-Shan Huang
Journal:  Pediatr Res       Date:  2004-08-19       Impact factor: 3.756

7.  Glucose-6-phosphate dehydrogenase deficiency and kernicterus of South-East anatolia.

Authors:  Selahattin Katar
Journal:  J Pediatr Hematol Oncol       Date:  2007-05       Impact factor: 1.289

8.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Authors: 
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

9.  UGT1A1 haplotype mutation among Asians in Singapore.

Authors:  Y Y Zhou; L Y Lee; S Y Ng; C P P Hia; K T Low; Y S Chong; D L M Goh
Journal:  Neonatology       Date:  2009-03-27       Impact factor: 4.035

10.  Development of icterus gravis in a preterm infant with G71R UGT1A1 polymorphism.

Authors:  Akimune Kaga; Yukimune Ohkubo; Yohei Watanabe; Sachiko Saito; Takuma Matsuki; Haruo Usuda; Susumu Kanda; Yutaka Suzuki; Muneyuki Tanabu; Shigeo Kure
Journal:  BMC Res Notes       Date:  2013-02-06
  10 in total
  2 in total

1.  Molecular Genetic Screening of Neonatal Intensive Care Units: Hyperbilirubinemia as an Example.

Authors:  Yuqi Yang; Yu Wang; Lingna Zhou; Wei Long; Bin Yu; Huaiyan Wang
Journal:  Appl Clin Genet       Date:  2022-05-18

2.  Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Level of Oatp2a1 and Oatp2b1.

Authors:  Yan Chen; Jiongshan Zhang; Mengting Liu; Zengcheng Zou; Fenglin Wang; Hao Hu; Baoguo Sun; Shijun Zhang
Journal:  Biomed Res Int       Date:  2019-07-29       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.